A novel carboxamide bromodomain inhibitor attenuates osteoarthritis via epigenetic repression of NF-κB and MAPK signaling
Hyemi Lee(Sungkyunkwan University), Siyoung Yang(Sungkyunkwan University)
Cited by 1
Related Papers
Blockade of Activin Receptor IIB Protects Arthritis Pathogenesis by Non‐Amplification of Activin A‐ACVR2B‐NOX4 Axis Pathway
|Advanced Science|2023|16
BRD2‐specific inhibitor, BBC0403, inhibits the progression of osteoarthritis pathogenesis in osteoarthritis‐induced C57BL/6 male mice
|British Journal of Pharmacology|2024|6
A Novel BD2-Selective Inhibitor of BRDs Mitigates ROS Production and OA Pathogenesis
|Antioxidants|2024|4
WGA-M001, a Mixture of Total Extracts of Tagetes erecta and Ocimum basilicum, Synergistically Alleviates Cartilage Destruction by Inhibiting ERK and NF-κB Signaling
|International Journal of Molecular Sciences|2023|2